These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 25084686)

  • 1. Comment on: CT analysis of the effect of pirfenidone in patients with idiopathic pulmonary fibrosis.
    Rea G; Bocchino M
    Eur J Radiol; 2014 Oct; 83(10):1988-9. PubMed ID: 25084686
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply to: comment on: CT analysis of the effect of pirfenidone in patients with idiopathic pulmonary fibrosis.
    Eur J Radiol; 2014 Oct; 83(10):1990. PubMed ID: 25112671
    [No Abstract]   [Full Text] [Related]  

  • 3. CT analysis of the effect of pirfenidone in patients with idiopathic pulmonary fibrosis.
    Iwasawa T; Ogura T; Sakai F; Kanauchi T; Komagata T; Baba T; Gotoh T; Morita S; Yazawa T; Inoue T
    Eur J Radiol; 2014 Jan; 83(1):32-8. PubMed ID: 22465123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary fibrolysis in a patient with idiopathic pulmonary fibrosis: improvement of clinical and radiological pattern after treatment with pirfenidone.
    Varone F; Mastrobattista A; Franchi P; Viglietta L; Poletti V; Tomassetti S; Dubini A; Tagliaboschi L; Calandriello L; Farchione A; Larici AR
    Clin Respir J; 2018 Jan; 12(1):347-351. PubMed ID: 27322356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deterioration of high-resolution computed tomography findings predicts disease progression after initial decline in forced vital capacity in idiopathic pulmonary fibrosis patients treated with pirfenidone.
    Higo H; Miyahara N; Taniguchi A; Senoo S; Itano J; Watanabe H; Oda N; Kayatani H; Ichikawa H; Shibayama T; Kajimoto K; Tanimoto Y; Kanehiro A; Maeda Y; Kiura K;
    Respir Investig; 2020 May; 58(3):185-189. PubMed ID: 32102769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eosinophilic pneumonia associated with pirfenidone therapy.
    Gomez DC; Mehrad B
    Eur Respir J; 2016 Oct; 48(4):1240-1242. PubMed ID: 27390279
    [No Abstract]   [Full Text] [Related]  

  • 7. Marked Improvement with Pirfenidone in a Patient with Idiopathic Pulmonary Fibrosis.
    Miyamoto A; Morokawa N; Takahashi Y; Ogawa K; Takeyasu M; Murase K; Hanada S; Uruga H; Mochizuki S; Takaya H; Kurosaki A; Kishi K
    Intern Med; 2016; 55(6):657-61. PubMed ID: 26984086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnostic criteria and possible treatment of idiopathic pulmonary fibrosis].
    Bendstrup E; Hyldgaard C; Hilberg O
    Ugeskr Laeger; 2014 Apr; 176(18):. PubMed ID: 25351567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Idiopathic pulmonary fibrosis: A guide for nurse practitioners.
    Vega-Olivo M; Criner GJ
    Nurse Pract; 2018 May; 43(5):48-54. PubMed ID: 29465476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials.
    Noble PW; Albera C; Bradford WZ; Costabel U; Glassberg MK; Kardatzke D; King TE; Lancaster L; Sahn SA; Szwarcberg J; Valeyre D; du Bois RM;
    Lancet; 2011 May; 377(9779):1760-9. PubMed ID: 21571362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [MODERN APPROACH TO THERAPY OF PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS].
    Tsvetkova OA; Voronkova OO; Buyanova OE
    Klin Med (Mosk); 2017; 95(3):281-5. PubMed ID: 30303652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct improvement of pulmonary function, ground-glass opacity, hypoxia and physical findings in an idiopathic pulmonary fibrosis patient after pirfenidone treatment : a case report with a review of the literature.
    Imakura T; Toyoda Y; Sato S; Koyama K; Nishimura H; Kagawa K; Takahashi N; Naito N; Murakami K; Kawano H; Azuma M; Shinohara T; Nishioka Y
    J Med Invest; 2020; 67(3.4):358-361. PubMed ID: 33148916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of pirfenidone on mortality: pooled analyses and meta-analyses of clinical trials in idiopathic pulmonary fibrosis.
    Nathan SD; Albera C; Bradford WZ; Costabel U; Glaspole I; Glassberg MK; Kardatzke DR; Daigl M; Kirchgaessler KU; Lancaster LH; Lederer DJ; Pereira CA; Swigris JJ; Valeyre D; Noble PW
    Lancet Respir Med; 2017 Jan; 5(1):33-41. PubMed ID: 27876247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pirfenidone Initiates a New Era in the Treatment of Idiopathic Pulmonary Fibrosis.
    Selvaggio AS; Noble PW
    Annu Rev Med; 2016; 67():487-95. PubMed ID: 26565677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced incidence of lung cancer in patients with idiopathic pulmonary fibrosis treated with pirfenidone.
    Miura Y; Saito T; Tanaka T; Takoi H; Yatagai Y; Inomata M; Nei T; Saito Y; Gemma A; Azuma A
    Respir Investig; 2018 Jan; 56(1):72-79. PubMed ID: 29325685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does pirfenidone have anticancer effects in patients with idiopathic pulmonary fibrosis?
    Tanino Y
    Respir Investig; 2018 Mar; 56(2):95-96. PubMed ID: 29548661
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy and adverse events of pirfenidone in treating idiopathic pulmonary fibrosis.
    Ren H; Wang K; Yang H; Gao L
    Saudi Med J; 2017 Sep; 38(9):889-894. PubMed ID: 28889145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase II trial evaluating the efficacy and safety of perioperative pirfenidone for prevention of acute exacerbation of idiopathic pulmonary fibrosis in lung cancer patients undergoing pulmonary resection: West Japan Oncology Group 6711 L (PEOPLE Study).
    Iwata T; Yoshino I; Yoshida S; Ikeda N; Tsuboi M; Asato Y; Katakami N; Sakamoto K; Yamashita Y; Okami J; Mitsudomi T; Yamashita M; Yokouchi H; Okubo K; Okada M; Takenoyama M; Chida M; Tomii K; Matsuura M; Azuma A; Iwasawa T; Kuwano K; Sakai S; Hiroshima K; Fukuoka J; Yoshimura K; Tada H; Nakagawa K; Nakanishi Y;
    Respir Res; 2016 Jul; 17(1):90. PubMed ID: 27450274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Idiopathic Pulmonary Fibrosis.
    Lederer DJ; Martinez FJ
    N Engl J Med; 2018 May; 378(19):1811-1823. PubMed ID: 29742380
    [No Abstract]   [Full Text] [Related]  

  • 20. Pirfenidone treatment in idiopathic pulmonary fibrosis: too much of a great expectation?
    Papiris SA; Kagouridis K; Kolilekas L; Triantafillidou C; Tsangaris I; Manali ED
    Eur Respir J; 2012 Sep; 40(3):794-5. PubMed ID: 22941551
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.